Supriya Lifescience (NSE:SUPRIYA) Change In Inventory: ₹ Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUPRIYA Supriya Lifescience Ltd NSE:SUPRIYA
81 GF Score
Price ₹906.30
GF Value ₹876.11
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Supriya Lifescience Change In Inventory?

Supriya Lifescience NSE:SUPRIYA +0.63% 81 Change In Inventory is ₹ Mil as of Jun. 2026. GuruFocus rates NSE:SUPRIYA with a GF Score™ of 81/100 and a GF Value™ of ₹876.11 (Fairly Valued). The stock has 7 warning signs investors should review.

Supriya Lifescience's change in inventory for the quarter that ended in Jun. 2026 was ₹ Mil. It means Supriya Lifescience's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Supriya Lifescience's change in inventory for the fiscal year that ended in Mar. 2026 was ₹-412 Mil. It means Supriya Lifescience's inventory increased by ₹412 Mil from Mar. 2025 to Mar. 2026 .

Supriya Lifescience's Total Inventories for the quarter that ended in Jun. 2026 was ₹0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Supriya Lifescience's Days Inventory for the quarter that ended in Jun. 2026 was 85.88.

Inventory Turnover measures how fast the company turns over its inventory within a year. Supriya Lifescience's Inventory Turnover for the quarter that ended in Jun. 2026 was 1.06.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Supriya Lifescience's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.47.


Supriya Lifescience  (NSE:SUPRIYA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Supriya Lifescience's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=882.915/938.15*365 / 4
=85.88

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Supriya Lifescience's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Supriya Lifescience's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Supriya Lifescience Change In Inventory Related Terms


Supriya Lifescience Change In Inventory Historical Data

* Premium members only.

The historical data trend for Supriya Lifescience's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supriya Lifescience Change In Inventory Chart

Supriya Lifescience Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Inventory
Get a 7-Day Free Trial Premium Member Only -198.32 -234.58 305.21 -331.00 -412.48

Supriya Lifescience Quarterly Data
Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
NSE:SUPRIYA
81GF Score
Supriya Lifescience Ltd NSE:SUPRIYA
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supriya Lifescience Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of ₹ Mil mean?
Supriya Lifescience (NSE:SUPRIYA) has a Change In Inventory of ₹ Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Supriya Lifescience and its competitors.
Is Supriya Lifescience's Change In Inventory too high?
Supriya Lifescience's current Change In Inventory is ₹ Mil. Overall, Supriya Lifescience has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Supriya Lifescience's Change In Inventory compare to VRTX and REGN?
Supriya Lifescience's Change In Inventory of ₹ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Supriya Lifescience and its competitors. Supriya Lifescience's current Change In Inventory is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supriya Lifescience stock overvalued right now?
Based on GuruFocus' analysis, Supriya Lifescience (NSE:SUPRIYA) is currently considered Fairly Valued. The stock's GF Value™ is ₹876.11, compared to a current price of ₹906.30 — trading 3.4% above its estimated fair value. The current Change In Inventory is ₹ Mil. Supriya Lifescience's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Supriya Lifescience (NSE:SUPRIYA), the current Change In Inventory is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supriya Lifescience (NSE:SUPRIYA) Overvalued in 2026?

Based on GuruFocus' analysis, Supriya Lifescience stock appears to be overvalued. The current stock price of ₹906.30 is trading 3.4% above its estimated GF Value™ of ₹876.11. GuruFocus considers Supriya Lifescience to be Fairly Valued.

Key valuation signals for NSE:SUPRIYA:

  • Change In Inventory: ₹ Mil
  • GF Value™: ₹876.11 vs. price of ₹906.30 (3.4% above fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the NSE:SUPRIYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Supriya Lifescience Business Description

Other Exchanges 543434:India
Address Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active Pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatic, and anti-allergic.
81GF Score

Get the complete analysis for NSE:SUPRIYA

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹906.30
Price
₹876.11
GF Value